Considerations for parenteral dosage form development of natural alpha interferon.
D002626:Chemistry, Pharmaceutical; D004355:Drug Stability; D005079:Excipients; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007370:Interferon Type I / Q000008:administration & dosage*; D013242:Sterilization / Q000379:methods; D013314:Stress, Mechanical
D005079:Excipients; D007370:Interferon Type I